Richwood Investment Advisors, LLC Amgen Inc Transaction History

Richwood Investment Advisors, LLC

$121 Million
Q3 2024

A detailed history of Richwood Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Richwood Investment Advisors, LLC holds 4,132 shares of AMGN stock, worth $1.09 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

4,132

Previous 4,194 1.48%

Holding current value

$1.09 Million

Previous $1.31 Million 1.6%

% of portfolio

1.1%

Previous 1.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $19,181 - $20,917	-62 Reduced 1.48%	4,132 $1.33 Million
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $315,300 - $383,172	1,200 Added 40.08%	4,194 $1.31 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $103,514 - $124,955	-385 Reduced 11.39%	2,994 $851,000
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $28,127 - $31,730	-110 Reduced 3.15%	3,379 $973,000
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $13,119 - $16,287	-60 Reduced 1.69%	3,489 $937,000
Q2 2023 Jul 21, 2023	SELL	$214.27 - $253.37 $18,427 - $21,789	-86 Reduced 2.37%	3,549 $787,000
Q1 2023 Apr 19, 2023	SELL	$225.79 - $275.2 $12,418 - $15,136	-55 Reduced 1.49%	3,635 $878,000
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $2,290 - $2,910	-10 Reduced 0.27%	3,690 $969,000
Q3 2022 Oct 27, 2022	SELL	$224.46 - $253.15 $33,669 - $37,972	-150 Reduced 3.9%	3,700 $834,000
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $8,074 - $8,985	35 Added 0.92%	3,850 $937,000
Q1 2022 Apr 28, 2022	SELL	$219.27 - $242.57 $20,830 - $23,044	-95 Reduced 2.43%	3,815 $923,000
Q4 2021 Feb 17, 2022	BUY	$198.88 - $227.6 $777,620 - $889,916	3,910 New	3,910 $880,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Richwood Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richwood Investment Advisors, LLC with notifications on news.

Account

Richwood Investment Advisors, LLC Amgen Inc Transaction History